Key result
Higher myocardial native T1 is linked to lower %-predicted VO₂peak 48 months after mild COVID-19.
Why the study?
Cardiovascular magnetic resonance has shown persistent perimyocardial inflammatory abnormalities after COVID-19, but their relationship with long-term aerobic capacity remains unclear.
Observational (n=132)
Effect estimate: β -0.25 per ms (95% CI -0.40 to -0.10)
p-value: p=< 0.001
Higher myocardial native T1 on CMR is independently associated with reduced long-term aerobic capacity in patients evaluated 4 years after mild COVID-19.
Higher native T1 may identify post-COVID exercise limitation; leaves open causal role and clinical utility.
BACKGROUND: Exercise intolerance is a common and incapacitating long-term consequence of COVID-19, even after mild acute illness. Cardiovascular magnetic resonance (CMR) studies have demonstrated persistent perimyocardial inflammatory abnormalities; however, their relationship with long-term aerobic capacity remains unclear. METHODS: In this prospective observational study, individuals without prior structural heart disease underwent standardised CMR, echocardiography, and cardiopulmonary exercise testing (CPET) at least 3 years after the initial COVID-19. The primary endpoint was the association between %-predicted VO₂peak (age-sex-body mass index (BMI) adjusted, Study of Health in Pomerania (SHIP) reference) and imaging parameters. Secondary analyses included lactate measurements and sex-stratified models. RESULTS: A total of 132 participants (mean age 49 ± 12 years; 68/132 (52%) male) were evaluated 48 months [interquartile range (IQR) 42-53] post-infection. Non-ischaemic perimyocardial enhancement was present in 34/132 (26%), whereas two participants had an unrecognised ischaemic scar. Male sex, higher BMI, lower age, and higher native T1 were associated with lower %-predicted VO₂peak in univariate models. In multivariate analysis, male sex, lower age, and higher native T1 (β = -0.25 per ms, 95% CI -0.40 to -0.10; p < 0.001) remained independent predictors of lower %-predicted VO₂peak. In total, 63/132 (48%) participants demonstrated %-predicted VO₂peak below predicted values. Sex-stratified multivariate analyses showed that higher native T1 (p<0.001) independently associated with lower %-predicted VO₂peak in both men and women, with lower age additionally retained in men. In a lactate-measured subgroup (n=73), higher resting lactate, higher native T1, male sex, and lower left atrial area were associated with lower %-predicted VO₂peak. CONCLUSIONS: In long-term follow-up of individuals with mild initial COVID-19 and no prior structural heart disease, aerobic capacity relative to predicted values was reduced in 48% of participants, particularly in men, and was independently associated with higher myocardial native T1. Native T1 and resting lactate, but not conventional structural measures or peak exercise.
No takes yet. Share an insight, caveat, or question.
Różewicz-Juraszek et al. (2026) conducted an observational in mild initial COVID-19 disease (n=132). Native T1 (CMR) was evaluated on association between %-predicted VO₂peak and imaging parameters (β -0.25 per ms, 95% CI -0.40 to -0.10, p=< 0.001). Higher myocardial native T1 was independently associated with lower %-predicted VO₂peak (β = -0.25 per ms; 95% CI -0.40 to -0.10; p < 0.001) at 48 months follow-up after mild COVID-19.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: